logo

For the Inventor, By the Inventor

Vienna, Austria

Apeiron Biologics Ag


USPTO Granted Patents = 15



Trademarks = 4

Forward Citations = 45

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Hans Loibner (13 out of 32 patents)

silverMedal Oliver Mutschlechner (7 out of 7 patents)

bronzeMedal Ruth Ladenstein (7 out of 7 patents)

4.  Manfred Schuster (7 out of 17 patents)

5.  Isabel Klier (5 out of 5 patents)

6.  Evelyne Janzek-Hawlat (4 out of 6 patents)

7.  Stefan Stranner (4 out of 5 patents)

8.  Bernhard Peball (4 out of 6 patents)

9.  Robert Weik (2 out of 6 patents)

10.  Bettina Wagner (2 out of 2 patents)

11.  Susanne Wiederkum (2 out of 2 patents)

12.  Franz Groiss (2 out of 2 patents)

13.  Holger Lode (2 out of 2 patents)

14.  Günther Lametschwandtner (2 out of 2 patents)

15.  Joseph Penninger (2 out of 3 patents)


15 patents:

1. 11597775 - Preparations and methods for treating a GD2 positive cancer (2023-03-07),
2. 11492412 - Preparations and methods for treating a GD2 positive cancer (2022-11-08),
3. 11447565 - Method for treating a GD2 positive cancer (2022-09-20),
4. 10995147 - Preparations and methods for treating a GD2 positive cancer (2021-05-04),
5. 10716833 - Method for producing ACE2 polypeptide (2020-07-21),
6. 10472341 - Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases (2019-11-12),
7. 10294305 - Method for treating a GD2 positive cancer (2019-05-21),
8. 9840566 - Preparations and methods for treating a GD2 positive cancer (2017-12-12),
9. 9777068 - Method for treating a GD2 positive cancer (2017-10-03),
10. 9561263 - Treatment of inflammatory illnesses with ACE2 (2017-02-07),
11. 9186373 - SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer (2015-11-17),
12. 8809288 - Method for increasing immunoreactivity (2014-08-19),
13. 8802084 - ACE2 activation for treatment of heart, lung and kidney disease and hypertension (2014-08-12),
14. 8586319 - Recombinant ACE2 polypeptide dimer (2013-11-19),
15. 8211426 - ACE2 activation for treatment of heart, lung and kidney disease and hypertension (2012-07-03),
APEIRON Biologics AG is a biotechnology company focused on the discovery, development, and commercialization of novel immunotherapies based on the transformative potential of the immune system. The company's mission is to improve the lives of cancer patients and those with severe respiratory diseases through innovative treatments. APEIRON Biologics AG is committed to advancing precision medicine and delivering effective therapies to patients in need.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#53 in Vienna

#218 in Austria

#38,719 in the World

...
Vienna, Austria

Apeiron Biologics Ag

Forward Citations = 45

32 inventors:

goldMedal Hans Loibner (13 out of 32 patents)

silverMedal Oliver Mutschlechner (7 out of 7 patents)

bronzeMedal Ruth Ladenstein (7 out of 7 patents)

4.  Manfred Schuster (7 out of 17 patents)

5.  Isabel Klier (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com
Loading…